Efficacy and Safety Study of Soluble Beta-1,3/1,6-glucan (SBG) Versus Placebo in Chronic Diabetic Foot Ulcers

A Randomised, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Soluble Beta-1,3/1,6-glucan (SBG) in Chronic Foot Ulcers in Patients With Diabetes

Evaluation of efficacy and safety of SBG vs placebo in the treatment of chronic diabetic foot ulcers.

The objective of this study is to evaluate efficacy and safety of soluble beta-1,3/1,6-glucan (SBG) on chronic diabetic foot ulcers.

Inclusion Criteria:

• Patients with chronic diabetic foot ulcer

Exclusion Criteria:

• Insufficient nutritional status, renal function or diabetes control